Cargando…

A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer

Germline mutations in the two breast cancer susceptibility genes, BRCA1 and BRCA2 account for a significant portion of hereditary breast/ovarian cancer. De novo mutations such as multiple exon deletion are rarely occurred in BRCA1 and BRCA2. During our mutation screening for BRCA1/2 genes to Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwong, Ava, Ng, Enders K. O., Tang, Edmund Y. H., Wong, Chris L. P., Law, Fian B. F., Leung, Candy P. H., Chan, Aaron, Cheung, M. T., To, M. Y., Ma, Edmond S. K., West, Dee W., Ford, James M.
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100488/
https://www.ncbi.nlm.nih.gov/pubmed/21404118
http://dx.doi.org/10.1007/s10689-011-9429-y
Descripción
Sumario:Germline mutations in the two breast cancer susceptibility genes, BRCA1 and BRCA2 account for a significant portion of hereditary breast/ovarian cancer. De novo mutations such as multiple exon deletion are rarely occurred in BRCA1 and BRCA2. During our mutation screening for BRCA1/2 genes to Chinese women with risk factors for hereditary breast/ovarian cancer, we identified a novel germline mutation, consisting of a deletion from exons 1 to 12 in BRCA1 gene, in a patient diagnosed with early onset triple negative breast cancer with no family history of cancer. None of her parents carried the mutation and molecular analysis showed that this novel de novo germline mutation resulted in down-regulation of BRCA1 gene expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10689-011-9429-y) contains supplementary material, which is available to authorized users.